328 related articles for article (PubMed ID: 30859275)
1. [Membranous glomerulonephritis : An example of individualized medicine in nephrology].
Stahl RAK; Hoxha E
Internist (Berl); 2019 May; 60(5):440-449. PubMed ID: 30859275
[TBL] [Abstract][Full Text] [Related]
2. Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy.
Wang J; Cui Z; Lu J; Probst C; Zhang YM; Wang X; Qu Z; Wang F; Meng LQ; Cheng XY; Liu G; Debiec H; Ronco P; Zhao MH
Clin J Am Soc Nephrol; 2017 Oct; 12(10):1642-1651. PubMed ID: 28801527
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China.
Zhang D; Zou J; Zhang C; Zhang W; Lin F; Jiang G
Med Sci Monit; 2018 Jul; 24():5076-5083. PubMed ID: 30032157
[TBL] [Abstract][Full Text] [Related]
4. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
Tomas NM; Beck LH; Meyer-Schwesinger C; Seitz-Polski B; Ma H; Zahner G; Dolla G; Hoxha E; Helmchen U; Dabert-Gay AS; Debayle D; Merchant M; Klein J; Salant DJ; Stahl RAK; Lambeau G
N Engl J Med; 2014 Dec; 371(24):2277-2287. PubMed ID: 25394321
[TBL] [Abstract][Full Text] [Related]
5. Antigen-Specific IgG Subclasses in Primary and Malignancy-Associated Membranous Nephropathy.
von Haxthausen F; Reinhard L; Pinnschmidt HO; Rink M; Soave A; Hoxha E; Stahl RAK
Front Immunol; 2018; 9():3035. PubMed ID: 30619370
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy.
Tomas NM; Hoxha E; Reinicke AT; Fester L; Helmchen U; Gerth J; Bachmann F; Budde K; Koch-Nolte F; Zahner G; Rune G; Lambeau G; Meyer-Schwesinger C; Stahl RA
J Clin Invest; 2016 Jul; 126(7):2519-32. PubMed ID: 27214550
[TBL] [Abstract][Full Text] [Related]
7. [Update membranous nephropathy].
Hoxha E; Huber TB
Dtsch Med Wochenschr; 2020 Oct; 145(20):1481-1485. PubMed ID: 33022730
[TBL] [Abstract][Full Text] [Related]
8. Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management.
Pozdzik A; Brochériou I; David C; Touzani F; Goujon JM; Wissing KM
Biomed Res Int; 2018; 2018():6281054. PubMed ID: 29511687
[TBL] [Abstract][Full Text] [Related]
9. Multi-Autoantibody Signature and Clinical Outcome in Membranous Nephropathy.
Ghiggeri GM; Seitz-Polski B; Justino J; Zaghrini C; Payré C; Brglez V; Dolla G; Sinico A; Scolari F; Vaglio A; Prunotto M; Candiano G; Radice A; Bruschi M; Lambeau G;
Clin J Am Soc Nephrol; 2020 Dec; 15(12):1762-1776. PubMed ID: 33257410
[TBL] [Abstract][Full Text] [Related]
10. Characterization of THSD7A-antibodies not binding to glomerular THSD7A in a patient with diabetes mellitus but no membranous nephropathy.
Reinhard L; Thomas C; Machalitza M; Lattwein E; Weiss LS; Vitu J; Wiech T; Stahl RAK; Hoxha E
Sci Rep; 2021 Aug; 11(1):16188. PubMed ID: 34376704
[TBL] [Abstract][Full Text] [Related]
11. Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy.
Zaghrini C; Seitz-Polski B; Justino J; Dolla G; Payré C; Jourde-Chiche N; Van de Logt AE; Booth C; Rigby E; Lonnbro-Widgren J; Nystrom J; Mariat C; Cui Z; Wetzels JFM; Ghiggeri G; Beck LH; Ronco P; Debiec H; Lambeau G
Kidney Int; 2019 Mar; 95(3):666-679. PubMed ID: 30784662
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical and serological characterization of membranous nephropathy in children and adolescents.
Dettmar AK; Wiech T; Kemper MJ; Soave A; Rink M; Oh J; Stahl RAK; Hoxha E;
Pediatr Nephrol; 2018 Mar; 33(3):463-472. PubMed ID: 29034405
[TBL] [Abstract][Full Text] [Related]
13. Circulating antibodies against M-type phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in Chinese patients with membranous nephropathy.
Tian C; Li L; Liu T; Qu X; Qiu Y
Int Urol Nephrol; 2019 Aug; 51(8):1371-1377. PubMed ID: 31227982
[TBL] [Abstract][Full Text] [Related]
14. Characterization of autoantibodies in primary membranous nephropathy and their clinical significance.
Stahl RA; Reinhard L; Hoxha E
Expert Rev Clin Immunol; 2019 Feb; 15(2):165-175. PubMed ID: 30433832
[No Abstract] [Full Text] [Related]
15. Membranous nephropathy-one morphologic pattern with different diseases.
Hoxha E; von Haxthausen F; Wiech T; Stahl RAK
Pflugers Arch; 2017 Aug; 469(7-8):989-996. PubMed ID: 28555350
[TBL] [Abstract][Full Text] [Related]
16. Membranous nephropathy: integrating basic science into improved clinical management.
Cattran DC; Brenchley PE
Kidney Int; 2017 Mar; 91(3):566-574. PubMed ID: 28065518
[TBL] [Abstract][Full Text] [Related]
17. Anti-PLA2R and anti-THSD7A as Diagnostic Serological Markers of Idiopathic Membranous Nephropathy: A Single Centre Study.
Fouad MA; Mahedy AW; Mansour AE; Fouad NA
Egypt J Immunol; 2020 Jun; 27(2):1-9. PubMed ID: 33548972
[TBL] [Abstract][Full Text] [Related]
18. Role of Serum and Urine Biomarkers (PLA
Maifata SM; Hod R; Zakaria F; Ghani FA
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32079308
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Membranous Nephropathy in Patients With THSD7A Antibodies Using Immunoadsorption.
Weinmann-Menke J; Holtz S; Sollinger D; Dörken M; Boedecker S; Schamberger B; Pfister F; Amann K; Lutz J
Am J Kidney Dis; 2019 Dec; 74(6):849-852. PubMed ID: 31451329
[TBL] [Abstract][Full Text] [Related]
20. [Membranous nephropathy: Pathophysiology and natural history].
Seitz-Polski B; Lambeau G; Esnault V
Nephrol Ther; 2017 Apr; 13 Suppl 1():S75-S81. PubMed ID: 28577747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]